Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and damage to the eyes.
Oral antidiabetic drugs have the advantages of convenience, quickness, and easy access, and are being accepted by patients. Manufacturers of oral antidiabetic drugs are also developing to produce drugs with better effects, and the global oral hypoglycemic drug market will continue to grow.
The global growth of the oral antidiabetic drug market is mainly due to the increased prevalence of diabetic patients worldwide. This growth has continued to occur in developing countries such as India and China. Also, factors leading to an increase in the global diabetes population include sedentary lifestyles, obesity, an increase in the elderly population, and lagging healthcare services. However, the high cost of the drug is expected to limit the growth of the global oral antidiabetic market. The increase in the number of pharmaceutical companies and the emergence of advanced technologies are the key factors driving the growth of this market.
This report elaborates on the current development of the Oral Antidiabetic Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Abbott
Sanofi
Novo Nordisk
Sunpharma
Pfizer
Novartis
Merck
Biocon
Eli Lilly
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors
Application:
Hospitals
Clinics
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Oral Antidiabetic Drugs Industry Overview
-
1.1.1 Oral Antidiabetic Drugs Market Scope and Market Segments
-
1.1.2 Oral Antidiabetic Drugs Industry Characteristics
-
1.1.3 Global and China Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Oral Antidiabetic Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Oral Antidiabetic Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Sulfonylureas
-
1.2.2 Meglitinides
-
1.2.3 Alpha-glucosidase inhibitors
-
1.3 Global Oral Antidiabetic Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Clinics
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Oral Antidiabetic Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Oral Antidiabetic Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Oral Antidiabetic Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Oral Antidiabetic Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Oral Antidiabetic Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Oral Antidiabetic Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Oral Antidiabetic Drugs Industry PEST Analysis
-
2.3 Oral Antidiabetic Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Oral Antidiabetic Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Oral Antidiabetic Drugs Industry
Chapter 3 Global and China Oral Antidiabetic Drugs Market, by Manufacturer
-
3.1 Global and China Oral Antidiabetic Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Oral Antidiabetic Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Oral Antidiabetic Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Oral Antidiabetic Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Oral Antidiabetic Drugs Market Top 3 Players
Chapter 4 Global and China Oral Antidiabetic Drugs Market, by Type (2017-2028)
-
4.1 Oral Antidiabetic Drugs Market Trend, by Type
-
4.2 Global Oral Antidiabetic Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Oral Antidiabetic Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Oral Antidiabetic Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Oral Antidiabetic Drugs Price Trend, by Type (2017-2028)
-
4.3 China Oral Antidiabetic Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Oral Antidiabetic Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Oral Antidiabetic Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Oral Antidiabetic Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Oral Antidiabetic Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Oral Antidiabetic Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Oral Antidiabetic Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Oral Antidiabetic Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Oral Antidiabetic Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Oral Antidiabetic Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Oral Antidiabetic Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Oral Antidiabetic Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Oral Antidiabetic Drugs Market Analysis
-
7.1 North America Oral Antidiabetic Drugs Market, by Type
-
7.2 North America Oral Antidiabetic Drugs Market, by Application
-
7.3 North America Oral Antidiabetic Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Oral Antidiabetic Drugs Market Analysis
-
8.1 Europe Oral Antidiabetic Drugs Market, by Type
-
8.2 Europe Oral Antidiabetic Drugs Market, by Application
-
8.3 Europe Oral Antidiabetic Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Oral Antidiabetic Drugs Market Analysis
-
9.1 APAC Oral Antidiabetic Drugs Market, by Type
-
9.2 APAC Oral Antidiabetic Drugs Market, by Application
-
9.3 APAC Oral Antidiabetic Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Oral Antidiabetic Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Oral Antidiabetic Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Oral Antidiabetic Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Oral Antidiabetic Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Oral Antidiabetic Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Oral Antidiabetic Drugs Company Profiles
-
11.1 Abbott
-
11.1.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Abbott Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.1.3 Abbott Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Sanofi
-
11.2.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Sanofi Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.2.3 Sanofi Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Novo Nordisk
-
11.3.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Novo Nordisk Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.3.3 Novo Nordisk Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Sunpharma
-
11.4.1 Sunpharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Sunpharma Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.4.3 Sunpharma Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Pfizer
-
11.5.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Pfizer Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.5.3 Pfizer Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Novartis
-
11.6.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Novartis Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.6.3 Novartis Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Merck
-
11.7.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Merck Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.7.3 Merck Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Biocon
-
11.8.1 Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Biocon Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.8.3 Biocon Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Eli Lilly
-
11.9.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Eli Lilly Oral Antidiabetic Drugs Product Profiles, Application and Specification
-
11.9.3 Eli Lilly Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Oral Antidiabetic Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Oral Antidiabetic Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Oral Antidiabetic Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Oral Antidiabetic Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Market Size and Growth Rate of Sulfonylureas (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Market Size and Growth Rate of Meglitinides (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Market Size and Growth Rate of Alpha-glucosidase inhibitors (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Market Size and Growth Rate of Clinics (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Oral Antidiabetic Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Oral Antidiabetic Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Oral Antidiabetic Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Oral Antidiabetic Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Oral Antidiabetic Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Oral Antidiabetic Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Oral Antidiabetic Drugs Market Share, by Manufacturer in 2022
-
Table Global Oral Antidiabetic Drugs Sales Volume, by Type (2017-2028)
-
Table Global Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Oral Antidiabetic Drugs Sales Value, by Type (2017-2028)
-
Table Global Oral Antidiabetic Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Price Trend, by Type (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Volume, by Type (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Value, by Type (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Oral Antidiabetic Drugs Price Trend, by Type (2017-2028)
-
Table Global Oral Antidiabetic Drugs Sales Volume, by Application (2017-2028)
-
Table Global Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Oral Antidiabetic Drugs Sales Value, by Application (2017-2028)
-
Table Global Oral Antidiabetic Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Oral Antidiabetic Drugs Sales Value Share, by Application (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Volume, by Application (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Value, by Application (2017-2028)
-
Table China Oral Antidiabetic Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Oral Antidiabetic Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Oral Antidiabetic Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Oral Antidiabetic Drugs Sales Volume, by Type (2017-2028)
-
Table North America Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Oral Antidiabetic Drugs Sales Volume, by Application (2017-2028)
-
Table North America Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Oral Antidiabetic Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Oral Antidiabetic Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Oral Antidiabetic Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Oral Antidiabetic Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Oral Antidiabetic Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Oral Antidiabetic Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oral Antidiabetic Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Oral Antidiabetic Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Oral Antidiabetic Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Oral Antidiabetic Drugs Sales Value and Growth Rate (2017-2028)
-
Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abbott Product Profiles, Application and Specification
-
Table Abbott Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sunpharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sunpharma Product Profiles, Application and Specification
-
Table Sunpharma Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biocon Product Profiles, Application and Specification
-
Table Biocon Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Oral Antidiabetic Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
